Amylyx Pharmaceuticals
Amylyx is seeking a highly experienced analytical development professional to lead phase-appropriate control strategies for drug substances and products, including peptides and oligonucleotides, supporting their pipeline of therapies for high unmet medical needs. The role involves managing analytical activities, collaborating cross-functionally, and authoring regulatory documentation in a fast-paced, innovative environment.
Headquarters
Cambridge, Massachusetts, United States
Company Size
201-500 employees
Amylyx Pharmaceuticals is a biopharmaceutical company focused on developing novel therapies for diseases with high unmet needs, including Post-Bariatric Hypoglycemia (PBH), Wolfram Syndrome, and Amyotrophic Lateral Sclerosis (ALS). Its lead program, Avexitide, is being evaluated in the pivotal Phase 3 LUCIDITY clinical trial for PBH. Amylyx advances its pipeline using rigorous science, well-defined mechanistic rationale, and a strong commitment to the patient communities it serves.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amylyx Pharmaceuticals.
Wall Street Zen Upgrades Amylyx Pharmaceuticals (NASDAQ:AMLX) Stock Rating
4 days ago
Scientist II, Analytical Development
PepGen
Bench Scientist New Modalities (all genders)
JobAps
Analytical Development Scientist / Quality Control
BridgeBio Pharma
12 Month – Work Placement Student - Analytical Chemistry
AstraZeneca
Senior Scientist New Modalities, Analytical
AstraZeneca
Scientist Analytical Sciences United States
alnylam